Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.14 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |